In a recent study from Brigham and Women’s Hospital and elsewhere, scientists found that the hormone aldosterone is actually a common and unrecognized contributor to high blood pressure. It is much more common than previously recognized.
High blood pressure affects more than 1.5 billion people worldwide and is arguably the leading preventable cause of heart disease and stroke.
Primary aldosteronism is a condition where the adrenal glands produce too much of the hormone aldosterone, which causes high blood pressure and heart disease.
The health condition has traditionally been considered to be an uncommon cause of high blood pressure.
In the study, researchers examined patients with normal blood pressure, stage 1 high blood pressure, stage 2 high blood pressure, and resistant high blood pressure to determine the prevalence of excess aldosterone production and primary aldosteronism.
They found that there was a continuum of excess aldosterone production that paralleled the severity of blood pressure.
Importantly, most of this excess aldosterone production would have not been recognized by currently recommended diagnostic approaches.
The finding supports the need to redefine primary aldosteronism from a rare disease to, instead, a common syndrome that manifests across a broad severity spectrum and may be a primary cause of high blood pressure.
Since generic medications that block the deleterious effects of aldosterone already exist and are easily available, these findings suggest that using these drugs more frequently to treat high blood pressure may be an effective way to lower the risk of heart disease.
If you care about high blood pressure, please read studies about how to control high blood pressure effectively, and vitamin B could help treat drug-resistant high blood pressure.
For more information about high blood pressure, please see recent studies about foods that could help lower high blood pressure, and results showing the best way to measure blood pressure.
The study was conducted by Jenifer M. Brown et al and published in the Annals of Internal Medicine.
Copyright © 2022 Knowridge Science Report. All rights reserved.
